| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
Yes | Grant |
DSM
|
Yes | Post-IPO Equity |
Vivo Capital
|
Yes | Post-IPO Equity |
Temasek Holdings
|
Yes | Post-IPO Equity |
|
|
Yes | Post-IPO Equity |
|
|
- | Post-IPO Equity |
John Doerr
|
- | Post-IPO Equity |
Wei-Wu He
|
- | Post-IPO Equity |
TotalEnergies Ventures
|
- | Post-IPO Equity |
|
|
- | Post-IPO Equity |
|
|
- | Post-IPO Equity |
|
|
- | Post-IPO Equity |
Cosan S.A.
|
- | Series D |
Procter & Gamble Company
|
- | Series D |
Khosla Ventures
|
- | Series C |
Kleiner Perkins
|
- | Series C |
TPG Growth
|
- | Series C |
Votorantim Novos Negocios
|
- | Series C |
DAG Ventures
|
- | Series B |